Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
The Prostate
|
January 1, 1986
Persistent blockade of the pituitary-gonadal axis in patients with prostatic carcinoma during chronic administration of D-Trp-6-LH-RH
D Gonzalez-Barcena, P Perez-Sanchez, H Berea-Dominguez, et al.
European Journal of Endocrinology
|
September 1, 1994
Inhibition of luteinizing hormone, follicle-stimulating hormone and sex-steroid levels in men and women with a potent antagonist analog of luteinizing hormone-releasing hormone, Cetrorelix (SB-75)
D Gonzalez-Barcena, M Vadillo Buenfil, E Garcia Procel, et al.
Urology
|
February 1, 1995
Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord
D Gonzalez-Barcena, M Vadillo-Buenfil, A Cortez-Morales, et al.
The Prostate
|
January 1, 1994
Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer
D Gonzalez-Barcena, M Vadillo-Buenfil, F Gomez-Orta, et al.
The Prostate
|
January 1, 1985
Treatment of advanced prostatic carcinoma with D-Trp-6-LH-RH
D Gonzalez-Barcena, P Perez-Sanchez, S Ureta-Sanchez, et al.
Human Reproduction (Oxford, England)
|
November 18, 1997
Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix
D Gonzalez-Barcena, R B Alvarez, E P Ochoa, et al.
International Journal of Fertility
|
January 1, 1974
Increased potency of four analogues of LH-releasing hormone in man
A J Kastin, A Arimura, D Gonzalez-Barcena, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
The Prostate
|
January 1, 1986
Persistent blockade of the pituitary-gonadal axis in patients with prostatic carcinoma during chronic administration of D-Trp-6-LH-RH
D Gonzalez-Barcena, P Perez-Sanchez, H Berea-Dominguez, et al.
European Journal of Endocrinology
|
September 1, 1994
Inhibition of luteinizing hormone, follicle-stimulating hormone and sex-steroid levels in men and women with a potent antagonist analog of luteinizing hormone-releasing hormone, Cetrorelix (SB-75)
D Gonzalez-Barcena, M Vadillo Buenfil, E Garcia Procel, et al.
Urology
|
February 1, 1995
Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord
D Gonzalez-Barcena, M Vadillo-Buenfil, A Cortez-Morales, et al.
The Prostate
|
January 1, 1994
Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer
D Gonzalez-Barcena, M Vadillo-Buenfil, F Gomez-Orta, et al.
The Prostate
|
January 1, 1985
Treatment of advanced prostatic carcinoma with D-Trp-6-LH-RH
D Gonzalez-Barcena, P Perez-Sanchez, S Ureta-Sanchez, et al.
Human Reproduction (Oxford, England)
|
November 18, 1997
Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix
D Gonzalez-Barcena, R B Alvarez, E P Ochoa, et al.
International Journal of Fertility
|
January 1, 1974
Increased potency of four analogues of LH-releasing hormone in man
A J Kastin, A Arimura, D Gonzalez-Barcena, et al.
Page
of 2